Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.025
Neutral
RSI(14)
36.559
Neutral
STOCH(KDJ)(9,3,3)
20.678
Neutral
ATR(14)
0.967
Low Volatility
CCI(14)
-149.832
Sell
Williams %R
86.989
Oversold
TRIX(12,20)
-0.231
Sell
StochRSI(14)
0.000
Sell
Acme United Corp
ACU37.350USD
-0.690-1.81%
Close 11/06, 16:00（ET）Quotes delayed by 15 min
141.90MMarket Cap
14.17P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Acme United Corp
Currency: USD Updated: 2025-11-06Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Acme United Corp's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
50.500
Target Price
+32.75%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Acme United Corp Highlights
StrengthsRisks
Acme United Corporation is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. It markets and sells through two main product categories: first aid and medical and cutting and sharpening. The first aid and medical category includes first aid and safety products, such as First Aid Only, PhysiciansCare, Pac-Kit, Spill Magic, First Aid Central, Med-Nap and Safety Made brands. Its cutting and sharpening categories include school, home and office products (Westcott brand). Brands under hardware, industrial and sporting goods products are Clauss and DMT. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, and sharpening tools. It is also a supplier of tactical, trauma and emergency response products. It sells its products to mass market and e-commerce retailers, wholesale, contract and retail stationery distributors, and hardware chains.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 194.49M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.35%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.35%.
Fairly Valued
The company’s latest PE is 14.10, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 3.22M shares, increasing 12.29% quarter-over-quarter.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.49.
Financial Health
Currency: USD Updated: 2025-11-06The company's current financial score is 7.50, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 49.06M, representing a year-over-year increase of 1.86%, while its net profit experienced a year-over-year increase of 14.51%.
Score
Financials
6.32
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.32
Operational Efficiency
7.77
Growth Potential
7.26
Shareholder Returns
8.81
Acme United Corp's Company Valuation
Currency: USD Updated: 2025-11-06The company’s current valuation score is 7.86, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 14.10, which is 143.09% below the recent high of 34.27 and 55.09% above the recent low of 6.33.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 63/210
No Data
Earnings Forecast
Currency: USD Updated: 2025-11-06The company’s current earnings forecast score is 9.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Acme United Corp is 50.50, with a high of 51.00 and a low of 50.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
50.500
Target Price
+32.75%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
62
Total
4
Median
6
Average
Company name
Ratings
Analysts
Acme United Corp
ACU
2
Apple Inc
AAPL
51
GE Vernova Inc
GEV
34
Tapestry Inc
TPR
22
Avantor Inc
AVTR
21
FMC Corp
FMC
21
1
2
3
...
13
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-11-06The company’s current price momentum score is 6.24, which is lower than the Healthcare Equipment & Supplies industry's average of 6.74. Sideways: Currently, the stock price is trading between the resistance level at 39.03 and the support level at 36.34, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
37.802
Sell
MA10
38.263
Sell
MA20
38.277
Sell
MA50
40.317
Sell
MA100
40.949
Sell
MA200
39.827
Sell
Institutional Confidence
Currency: USD Updated: 2025-11-06Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
The Capital Management Corporation
Mink Brook Asset Management LLC
Johnsen (Walter C)
North Star Investment Management Corporation
Dimensional Fund Advisors, L.P.
BlackRock Institutional Trust Company, N.A.
Bard Associates Inc.
1
2
Risk Assessment
Currency: USD Updated: 2025-11-06The company’s current risk assessment score is 3.86, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.72. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.72
VaR
+3.99%
240-Day Maximum Drawdown
+22.97%
240-Day Volatility
+38.53%
Return
Best Daily Return
60 days
+7.84%
120 days
+7.84%
5 years
+18.73%
Worst Daily Return
60 days
-6.13%
120 days
-6.13%
5 years
-13.95%
Sharpe Ratio
60 days
-1.47
120 days
-0.16
5 years
+0.35
Risk Assessment
Maximum Drawdown
240 days
+22.97%
3 years
+32.93%
5 years
+53.67%
Return-to-Drawdown Ratio
240 days
-0.42
3 years
+0.66
5 years
+0.07
Skewness
240 days
+0.47
3 years
+0.59
5 years
+0.57
Volatility
Realised Volatility
240 days
+38.53%
5 years
+49.22%
Standardised True Range
240 days
+3.45%
5 years
+3.75%
Downside Risk-Adjusted Return
120 days
-28.61%
240 days
-28.61%
Maximum Daily Upside Volatility
60 days
+27.38%
Maximum Daily Downside Volatility
60 days
+24.62%
Liquidity
Average Turnover Rate
60 days
+0.50%
120 days
+0.43%
5 years
--
Turnover Deviation
20 days
-49.19%
60 days
+13.18%
120 days
-2.35%
Peer Comparison
Healthcare Equipment & Supplies
Acme United Corp
ACU
7.19 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
CSTL
8.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
